These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 29036256)

  • 21. A phase I, randomized, open-label, crossover study of the single-dose pharmacokinetic properties of guanfacine extended-release 1-, 2-, and 4-mg tablets in healthy adults.
    Swearingen D; Pennick M; Shojaei A; Lyne A; Fiske K
    Clin Ther; 2007 Apr; 29(4):617-25. PubMed ID: 17617285
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety and efficacy of a new extended-release formulation of minocycline.
    Fleischer AB; Dinehart S; Stough D; Plott RT; ;
    Cutis; 2006 Oct; 78(4 Suppl):21-31. PubMed ID: 17436826
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Azithromycin compared with minocycline in the treatment of acne comedonica and papulo-pustulosa.
    Gruber F; Grubisić-Greblo H; Kastelan M; Brajac I; Lenković M; Zamolo G
    J Chemother; 1998 Dec; 10(6):469-73. PubMed ID: 9876055
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Pharmacokinetics, Safety and Exploratory Efficacy Study of a Topical Bactericidal VB-1953: Analysis of Single and Multiple Doses in a Phase I Trial in Acne Vulgaris Subjects.
    Jain S; Yadav V; Bhatia N
    Clin Drug Investig; 2020 Mar; 40(3):259-268. PubMed ID: 31927743
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of combined azelaic acid cream plus oral minocycline with oral isotretinoin in severe acne.
    Gollnick HP; Graupe K; Zaumseil RP
    Eur J Dermatol; 2001; 11(6):538-44. PubMed ID: 11701404
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and Pharmacokinetics of Once-Daily Dapsone Gel, 7.5% in Patients With Moderate Acne Vulgaris.
    Jarratt MT; Jones TM; Chang-Lin JE; Tong W; Berk DR; Lin V; Kaoukhov A
    J Drugs Dermatol; 2016 Oct; 15(10):1250-1259. PubMed ID: 27741344
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Topical Minocycline Foam for the Treatment of Impetigo in Children: Results of a Randomized, Double-Blind, Phase 2 Study.
    Chamny S; Miron D; Lumelsky N; Shalev H; Gazal E; Keynan R; Shemer A; Tamarkin D
    J Drugs Dermatol; 2016 Oct; 15(10):1238-1243. PubMed ID: 27741342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of five antimicrobial regimens for treatment of mild to moderate inflammatory facial acne vulgaris in the community: randomised controlled trial.
    Ozolins M; Eady EA; Avery AJ; Cunliffe WJ; Po AL; O'Neill C; Simpson NB; Walters CE; Carnegie E; Lewis JB; Dada J; Haynes M; Williams K; Williams HC
    Lancet; 2004 Dec 18-31; 364(9452):2188-95. PubMed ID: 15610805
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and Safety of Sarecycline, a Novel, Once-Daily, Narrow Spectrum Antibiotic for the Treatment of Moderate to Severe Facial Acne Vulgaris: Results of a Phase 2, Dose-Ranging Study.
    Leyden JJ; Sniukiene V; Berk DR; Kaoukhov A
    J Drugs Dermatol; 2018 Mar; 17(3):333-338. PubMed ID: 29537451
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A double-blind comparison of topical clindamycin and oral minocycline in the treatment of acne vulgaris.
    Sheehan-Dare RA; Papworth-Smith J; Cunliffe WJ
    Acta Derm Venereol; 1990; 70(6):534-7. PubMed ID: 1981436
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetic Profile, Safety, and Tolerability of Clascoterone (Cortexolone 17-alpha propionate, CB-03-01) Topical Cream, 1% in Subjects With Acne Vulgaris: An Open-Label Phase 2a Study.
    Mazzetti A; Moro L; Gerloni M; Cartwright M
    J Drugs Dermatol; 2019 Jun; 18(6):563. PubMed ID: 31251549
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of Systemic Antibiotic Treatment of Acne With Skin Microbiota Characteristics.
    Chien AL; Tsai J; Leung S; Mongodin EF; Nelson AM; Kang S; Garza LA
    JAMA Dermatol; 2019 Apr; 155(4):425-434. PubMed ID: 30758497
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generic, twice-daily minocycline versus branded, extended-release minocycline for acne: A retrospective comparison of treatment escalation.
    Gupta P; Shin T; Sopkovich J; Massick S; Kaffenberger BH
    J Am Acad Dermatol; 2017 Jun; 76(6):1195-1197. PubMed ID: 28522046
    [No Abstract]   [Full Text] [Related]  

  • 34. BPX-01 Minocycline Topical Gel Shows Promise for the Treatment of Moderate-to-severe Inflammatory Acne Vulgaris.
    Alexis A; Del Rosso JQ; Desai SR; Downie JB; Draelos ZD; Feser C; Forconi R; Fowler JF; Gold M; Kaufman-Janette J; Lain E; Lee M; Ling M; Shamban AT; Werschler WP; Daniels A
    J Clin Aesthet Dermatol; 2018 Nov; 11(11):25-35. PubMed ID: 30588271
    [No Abstract]   [Full Text] [Related]  

  • 35. Open-label Extension Study Evaluating Long-term Safety and Efficacy of FMX101 4% Minocycline Foam for Moderate-to-Severe Acne Vulgaris.
    Stein Gold L; Dhawan S; Weiss J; Draelos ZD; Ellman H; Stuart I
    J Clin Aesthet Dermatol; 2019 Oct; 12(10):16-23. PubMed ID: 32038744
    [No Abstract]   [Full Text] [Related]  

  • 36. A single centre, open-label, cross-over study of pharmacokinetics comparing topical zinc/clindamycin gel (Zindaclin) and topical clindamycin lotion (Dalacin T) in subjects with mild to moderate acne.
    Chassard D; Kanis R; Namour F; Evene E; Ntssikoussalabongui B; Schmitz V
    J Dermatolog Treat; 2006; 17(3):154-7. PubMed ID: 16854755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Phase II, Randomized, Double-Blind Clinical Study Evaluating the Safety, Tolerability, and Efficacy of a Topical Minocycline Foam, FMX103, for the Treatment of Facial Papulopustular Rosacea.
    Mrowietz U; Kedem TH; Keynan R; Eini M; Tamarkin D; Rom D; Shirvan M
    Am J Clin Dermatol; 2018 Jun; 19(3):427-436. PubMed ID: 29396702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of Dapsone 5% Gel as Maintenance Treatment of Acne Vulgaris Following Completion of Oral Doxycycline and Dapsone 5% Gel Combination Treatment.
    Kircik LH
    J Drugs Dermatol; 2016 Feb; 15(2):191-5. PubMed ID: 26885787
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of topical minocycline foam (FMX101 4%) in treatment of Chinese subjects with moderate-to-severe facial acne vulgaris: A phase 3, multi-centre, randomized, double-blind, vehicle-controlled study.
    Le Y; Yang W; Lu J; Jiang X; Guo Q; Huang C; Sun Q; Wang H; Bi M; Wang H; Geng S; Yang B; Xu AE; Cui Y; Man X; Zhao Y; Zhang L; Li L; Song Z; Chen J; Cheng H; Zhu W; Han X; Li S; Lin T; Zhang C; Li J; Li Y; Ding Y; Wang L; Zhu Y; Xiang L
    J Eur Acad Dermatol Venereol; 2024 Jul; ():. PubMed ID: 38948962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of the efficacy and safety of lymecycline and minocycline in patients with moderately severe acne vulgaris.
    Grosshans E; Belaïch S; Meynadier J; Alirezai M; Thomas L
    Eur J Dermatol; 1998; 8(3):161-6. PubMed ID: 9649660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.